- After-Shows
- Alternative
- Animals
- Animation
- Arts
- Astronomy
- Automotive
- Aviation
- Baseball
- Basketball
- Beauty
- Books
- Buddhism
- Business
- Careers
- Chemistry
- Christianity
- Climate
- Comedy
- Commentary
- Courses
- Crafts
- Cricket
- Cryptocurrency
- Culture
- Daily
- Design
- Documentary
- Drama
- Earth
- Education
- Entertainment
- Entrepreneurship
- Family
- Fantasy
- Fashion
- Fiction
- Film
- Fitness
- Food
- Football
- Games
- Garden
- Golf
- Government
- Health
- Hinduism
- History
- Hobbies
- Hockey
- Home
- How-To
- Improv
- Interviews
- Investing
- Islam
- Journals
- Judaism
- Kids
- Language
- Learning
- Leisure
- Life
- Management
- Manga
- Marketing
- Mathematics
- Medicine
- Mental
- Music
- Natural
- Nature
- News
- Non-Profit
- Nutrition
- Parenting
- Performing
- Personal
- Pets
- Philosophy
- Physics
- Places
- Politics
- Relationships
- Religion
- Reviews
- Role-Playing
- Rugby
- Running
- Science
- Self-Improvement
- Sexuality
- Soccer
- Social
- Society
- Spirituality
- Sports
- Stand-Up
- Stories
- Swimming
- TV
- Tabletop
- Technology
- Tennis
- Travel
- True Crime
- Episode-Games
- Visual
- Volleyball
- Weather
- Wilderness
- Wrestling
- Other
AI & the Pharmaceutical Industry (Many Companies Are Closer Than They Think!) — A Conversation with Andy Alasso of Aizon
At the most recent edition of the Pharma Manufacturing World Summit we sat down with Andy Alasso, Aizon's Chief Product and Customer Successor Officer, to talk about what Artificial Intelligence is going to do for Pharmaceutical Manufacturers now, in the near-future, and in the years to come. It may surprise many business leaders to learn they are closer to being ready to incorporate AI tools into their existing toolbox than they think. The very nature of pharmaceutical manufacturing, which is data-centric by nature, lends itself well to AI. What should industry leaders be thinking about and learning about when it comes to these powerful new tools? Give this episode a listen to find out! <br/><br/>--<br/><br/>Andy Alasso<br/>Chief Product and Customer Success Officer<br/>Aizon<br/><br/>Andy Alasso is the Chief Product and Customer Success Officer at Aizon. At Aizon Andy is responsible for leading product delivery of the Aizon AI Cloud GxP platform designed to optimize manufacturing in Life Sciences. Prior to Aizon, Andy was Global Vice President of Product Management within the Oracle Health Sciences Business Unit. Andy and his team were responsible for defining, specifying, and facilitating the delivery of 20+ products within Oracle’s Clinical Research, Pharmacovigilance, and Healthcare portfolios. Prior to his role at Oracle, Andy led product management for several product portfolios within Healthcare services company Optum. Prior to Optum, Andy was Director of Clinical and Regulatory IT at Astra USA (now part of AstraZeneca). Overall Andy has over 25 years of experience in providing software solutions to the Life Sciences and Healthcare industries.<br/><br/>--<br/><br/>Aizon is an AI software provider that transforms manufacturing operations with the use of advanced analytics, artificial intelligence, and other smart factory technologies focused on optimizing production and quality within highly regulated industries. The Aizon platform seamlessly integrates unlimited sources of structured and unstructured data to deliver actionable insights across all manufacturing sites. Aizon offers an intuitive way to gain meaningful operational intelligence by enabling real-time visibility and predictive insights in a GxP compliant manner with end-to-end data integrity.www.aizon.ai